TENAX THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
TENAX THERAPEUTICS, INC. (TENX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-07-31
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2016-03-31 was 0.00%.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2017 was 0.00%.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2016 was 0.00%.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2015 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 8 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-07-31 | ||||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-12 | ||||
| 2024-09-30 | 0.00% 10-Q · filed 2024-11-13 | ||||
| 2024-06-30 | 0.00% 10-Q · filed 2024-08-13 | ||||
| 2024-03-31 | 0.00% 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | 0.00% 10-K · filed 2024-03-28 | ||||
| 2023-09-30 | 0.00% 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | 0.00% 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | 0.00% 10-Q · filed 2023-05-15 | ||||
| 2018-09-30 | 0.00% 10-Q · filed 2018-11-14 | ||||
| 2018-06-30 | 0.00% 10-Q · filed 2018-08-14 | ||||
| 2017-12-31 | 0.00% 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | 0.00% 10-Q · filed 2018-11-14 | ||||
| 2017-06-30 | 0.00% 10-Q · filed 2018-08-14 | ||||
| 2016-12-31 | 0.00% 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | 0.00% 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | 0.00% 10-Q · filed 2017-08-09 | ||||
| 2016-03-31 | 0.00% 10-Q · filed 2016-05-10 | ||||
| 2015-12-31 | 0.00% 10-K · filed 2017-03-16 | ||||
| 2015-10-31 | 0.00% 10-Q · filed 2015-12-10 | ||||
| 2015-09-30 | 0.00% 10-Q · filed 2016-11-09 | ||||
| 2015-07-31 | 0.00% 10-Q · filed 2015-09-09 | ||||
| 2015-06-30 | 0.00% 10-Q · filed 2016-08-09 | ||||
| 2015-04-30 | 0.00% 10-K · filed 2017-03-16 | ||||
| 2015-03-31 | 0.00% 10-Q · filed 2016-05-10 | ||||
| 2015-01-31 | 0.00% 10-Q · filed 2015-03-17 | ||||
| 2014-10-31 | 0.00% 10-Q · filed 2015-12-10 | ||||
| 2014-07-31 | 0.00% 10-Q · filed 2015-09-09 | ||||
| 2014-04-30 | 0.00% 10-K · filed 2017-03-16 | ||||
| 2014-01-31 | 0.00% 10-Q · filed 2015-03-17 | ||||
| 2013-10-31 | 0.00% 10-Q · filed 2014-12-15 | ||||
| 2013-07-31 | 0.00% 10-Q · filed 2014-09-15 | ||||
| 2013-04-30 | 0.00% 10-KT · filed 2016-03-14 | ||||
| 2013-01-31 | 0.00% 10-Q · filed 2014-03-17 | ||||
| 2012-10-31 | 0.00% 10-Q · filed 2013-12-17 | ||||
| 2012-07-31 | 0.00% 10-Q · filed 2013-09-17 | ||||
| 2012-04-30 | 0.00% 10-K · filed 2013-06-26 | ||||
| 2012-01-31 | 0.00% 10-Q · filed 2013-03-18 | ||||
| 2011-10-31 | 0.00% 10-Q · filed 2012-12-14 | ||||
| 2011-07-31 | 0.00% 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |